Page 1
Page 1
img

Manifestations dermatologiques des connectivites vascularites et affections systémiques apparentées : Dermatologie et médecine = Dermatological manifestations of connectivitis, vasculitis and related systemic conditions: Dermatology and medicine

Deals with all the skin and mucous membrane manifestations observed during the various so-called systemic, common or rare diseases. Each chapter covers in an exhaustive and original way the clinical, anatomopathological and therapeutic knowledge essential to the practice of dermatology and internal medicine. The work is abundantly illustrated with color clinical iconography, carefully selected for its clinical representativeness. The didactic anatomopathological figures have been enriched with explanatory diagrams facilitating their reading by the practitioner unfamiliar with dermatological histology. Produced by a group of leading authors in their field, this book is intended for dermatologists, rheumatologists and internists as well as all professionals concerned with systemic diseases and internal medicine.

img

Common Dermatologic Conditions in Primary Care

This book offers a guide to common dermatologic conditions most often treated by primary care providers. Most dermatologic disorders in the United States are treated by primary care physicians, and yet primary care training programs do not prioritize dermatology. This easy-to-use reference answers that need with practical recommendations for diagnosing and treating these common diseases along with a number of illustrative color images. Throughout, chapters are either organized by population and the dermatologic conditions common to those groups or diseases commonly encountered in primary care. Populations covered include children, pregnant women, and athletes, and common diseases covered include dermatitis, warts, herpes, psoriasis, and some skin cancers.

img

Animal Models of T Cell-Mediated Skin Diseases

Pharmaceutical companies are spending increasing amounts of money on drug discovery and development. Nevertheless, attrition rates in clinical development are still very high, and up to 90% of new compounds fail in clinical phase I - III trials, which is partially due to lack of clinical efficacy. This indicates a strong need for highly predictive in vitro and in vivo models. The "50th International Workshop of the Ernst Schering Research Foundation" focussed on "Animal Models of T Cell-Mediated Skin Diseases". Such animal models should have impact not only on inflammatory dermatoses but also on other inflammatory disorders due to their model character. The current volume summarises recent advances in animal research that are important for anti-inflammatory drug discovery.

Results Per Page